 Acorda Therapeutics Inc NASDAQ: ACOR announced that Esteve Pharmaceuticals GmbH launched INBRIJA 33 mg levodopa inhalation powder, hard capsules in Germany. INBRIJA is indicated in the EU for the intermittent treatment of episodic motor fluctuations OFF episodes in. 